PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
CCL2 3,560 Target Target CXCL11 526 48 0.04 -0.95 0.09 0.74
CXCL11 526 Target Target CXCL3 145 12 0.04 -0.95 0.08 0.78
Endotoxin receptor 115 Target Disease Sepsis 64,798 12 0.00 -0.95 0.10 0.61
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
Phospholipase A2 13,400 Target Target Platelet Activating Factor 9,915 614 0.05 -0.95 0.06 0.75
Complement Decay-Accelerating Factor 19 Target Disease Cancer 1,053,491 2 0.00 -0.95 0.11 0.54
BD2 76 Target Disease Cancer 1,053,491 8 0.00 -0.95 0.11 0.54
Kallikrein-8 19 Target Disease Inflammation 252,734 2 0.00 -0.95 0.11 0.57
Kallikrein-8 19 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
CD4 112,219 Target Target Eotaxin-2/CCL24 19 2 0.00 -0.95 0.11 0.59
Complement Decay-Accelerating Factor 19 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.11 0.59
Collagen 138,882 Target Target Beta-R1 38 4 0.00 -0.95 0.11 0.59
CD68 6,424 Target Target CD34 24,598 546 0.04 -0.95 0.08 0.72
Kallikrein-8 19 Target Disease Psoriasis 26,882 2 0.00 -0.95 0.11 0.62
CCL2 3,560 Target Target Eotaxin-2/CCL24 19 2 0.01 -0.95 0.11 0.67
CCL4 5,638 Target Target CXCL3 145 15 0.02 -0.95 0.10 0.69
Tegument Protein Vp16 19 Target Disease Genital Herpes 2,660 2 0.01 -0.95 0.11 0.68
Arachidonate 5-Lipoxygenase 170 Target Disease Leukemia 162,805 18 0.00 -0.95 0.11 0.59
EPHB3 118 Target Target EPHA3 140 7 0.05 -0.95 0.06 0.82
Epidermal Growth Factor Receptor 24,772 Target Drug Alimta (Pemetrexed)- FDA 28 3 0.00 -0.94 0.11 0.63
AGP 2,006 Target Disease Inflammation 252,734 214 0.01 -0.94 0.11 0.60
Alpha-2a Adrenergic Receptor 188 Target Disease Attention Deficit Hyperactivity Disorder 14,687 20 0.01 -0.94 0.11 0.67
EPHA2 532 Target Target EPHB1 137 12 0.04 -0.94 0.09 0.78
DDR2 194 Target Disease Carcinoma 433,099 21 0.00 -0.94 0.11 0.57
Angiotensin Converting Enzyme 31,674 Target Disease Proteinuria 28,803 1,681 0.06 -0.94 0.06 0.74
CCL7 274 Target Target CXCL9 1,016 24 0.05 -0.94 0.09 0.77
Trace Amine-Associated Receptor 1 64 Target Disease Schizophrenia 77,034 7 0.00 -0.94 0.11 0.61
EPHB1 137 Target Disease Pain 409,851 15 0.00 -0.94 0.11 0.57
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
AFP 9,751 Target Disease Hepatitis 163,842 1,023 0.03 -0.94 0.10 0.65
CA 72-4 184 Target Target AFP 9,751 20 0.01 -0.94 0.11 0.68
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
Carbonic Anhydrase 4 9 Target Disease Inflammation 252,734 1 0.00 -0.94 0.11 0.57
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Cholesterol 182,390 1 0.00 -0.94 0.11 0.57
Collagen 138,882 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.58
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Schizophrenia 77,034 1 0.00 -0.94 0.11 0.59
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Seizures 66,465 1 0.00 -0.94 0.11 0.59
Epigen 27 Target Disease Breast Cancer 173,695 3 0.00 -0.94 0.11 0.58
Exodus-2 27 Target Disease Leukemia 162,805 3 0.00 -0.94 0.11 0.58
Cox-2 21,583 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.62
FABP1 90 Target Disease Cholesterol 182,390 10 0.00 -0.94 0.11 0.59
Dopamine Receptor D3 45 Target Disease Schizophrenia 77,034 5 0.00 -0.94 0.11 0.60
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.94 0.11 0.63
bFGF 9,327 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.64
CD68 6,424 Target Target Carbonic Anhydrase 4 9 1 0.00 -0.94 0.11 0.65
CCL4 5,638 Target Target CXCL4/PF4 9 1 0.00 -0.94 0.11 0.65
CD95 4,266 Target Target CD254 9 1 0.01 -0.94 0.11 0.66
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Overactive Bladder 3,492 1 0.01 -0.94 0.11 0.67
Androgen Receptor 12,918 Target Target Steroid 5-Alpha-Reductase 293 32 0.02 -0.94 0.11 0.68
Cathepsin G 1,613 Target Target CINC-2- alpha 9 1 0.01 -0.94 0.11 0.69